Sistemic,
the stem cell and drug development technology company, has won a
substantial Scottish Regional Selective Assistance (RSA) grant from
Scottish Enterprise. The grant forms part of a £1M planned investment
programme which, on the back of a very successful year for the company,
will see Sistemic more than double the size of its operation. To
accommodate the expanded research team, the company is relocating to customised laboratories during the first half of 2012.
Jim
Reid, Sistemic ‘s Chairman and CEO said, "Securing this support from
Scottish Enterprise is a major achievement and shows great support by
the Scottish Government for what we are doing. It adds to an already
successful year for Sistemic, a year which has seen us grow sales
dramatically and develop our customer base in Europe, USA, Japan and
Australia. We truly have become a global company during 2011 and we look
forward to relocating in the first half of 2012 to allow this success
and growth to continue. It is always an exciting opportunity to be on
the lookout for new employees and we are ideally placed to recruit top
talent. This type of grant support is crucial to help grow successful
research focused biotech companies such as ours and we will ensure we
make the most of it!"
"We
work very closely with some of the world's leading stem cell and
pharmaceutical companies and we need to continually review our
operations to make sure that we have the best technology and services
and we need a facility which suits our needs," explains Reid. "The world
is waking-up to the incredible opportunities offered by stem cell
technology. Opportunities which show great promise to prolong healthy
life and Sistemic is already a key part of this burgeoning worldwide
industry."
Sistemic‘s SistemRNA
TM, SistemQC
TM, SistemKB
TM and
SistemTOX
TM products have brought new depth to miRNA analysis, which has
been shown to add value to drug discovery, cell therapeutics and
diagnostics. For 2012 the company looks forward to increased business and growing their client network around the world.
For further information on Sistemic and Sistemic miRNA analysis products, please visit:
www.sistemic.co.ukRegional
Selective Assistance (RSA) is the main investment grant scheme in areas
of Scotland designated for regional aid under European Community law.
RSA funding is available to create or safeguard jobs for both Scottish
owned businesses and inward investors. For further information visit the
Scottish Development International website:
http://www.sdi.co.uk/
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.